Add Company
Join Now

Pathalys Pharma Revenue and Competitors

License our Company Data API

Location

$266M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Pathalys Pharma's estimated annual revenue is currently $1.2M per year.(i)
  • Pathalys Pharma's estimated revenue per employee is $77,500
  • Pathalys Pharma's total funding is $266M.

Employee Data

  • Pathalys Pharma has 16 Employees.(i)
  • Pathalys Pharma grew their employee count by 60% last year.

Pathalys Pharma's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
Chief Operating OfficerReveal Email/Phone
4
SVP FinanceReveal Email/Phone
5
SVP, Technical OperationsReveal Email/Phone
6
VP FinanceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11.9M777%N/AN/A
#2
$6221.7M40140-4%N/AN/A
#3
$2M130%N/AN/A
#4
$0.8M5-55%N/AN/A
#5
$2.8M186%$11.1MN/A
#6
$1M13-41%N/AN/A
#7
$1.7M110%N/AN/A
#8
$0.6M40%N/AN/A
#9
$5.9M38-5%N/AN/A
#10
$6.8M447%N/AN/A
Add Company

What Is Pathalys Pharma?

Pathalys Pharma is a private, late-stage clinical biopharmaceutical company committed to the development of advanced therapeutics that address unmet needs in the management of late-stage chronic kidney disease (CKD). Pathalys was created in partnership with Catalys Pacific and DaVita to become a multi-asset pharmaceutical company focused on the needs of patients with end-stage renal disease.

keywords:N/A

$266M

Total Funding

16

Number of Employees

$1.2M

Revenue (est)

60%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M1623%N/A
#2
$1.7M16-36%N/A
#3
$1.4M1614%N/A
#4
$4M1678%N/A
#5
$2.4M167%N/A